Correlating Ic/Pbs Symptoms With Urine Biomarkers

This study has been completed.
Sponsor:
Information provided by:
William Beaumont Hospitals
ClinicalTrials.gov Identifier:
NCT00817388
First received: January 5, 2009
Last updated: June 4, 2010
Last verified: June 2010
  Purpose

Completion of a brief survey tool and providing an urine specimen. The study purpose is to improve our understanding of interstitial cystitis and painful pelvic syndrome.


Condition Intervention
Interstitial Cystitis
Pelvic Pain
Other: No intervention

Study Type: Observational
Official Title: Correlating Ic/Pbs Symptoms With Urine Biomarkers

Resource links provided by NLM:


Further study details as provided by William Beaumont Hospitals:

Primary Outcome Measures:
  • To correlate IC/PBS symptoms with urine biomarkers [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Biospecimen Retention:   Samples Without DNA

Urine specimen.


Enrollment: 26
Study Start Date: January 2009
Study Completion Date: May 2010
Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
1
patients will be asked to provide a urine specimen and complete a questionnaire.
Other: No intervention
No intervention

Detailed Description:

The purpose of the study is to improve our understanding of the IC/PBS and develop new treatments. Participation in the study will allow us to compare clinical information, obtained by completion of a brief survey, with substances found in the a urine specimen that is donated to the Beaumont Biobank.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patients with and without intersitial cystitis/painful pelvic pain will be asked to provide an urine specimen and complete a brief questionnaire.

Criteria

Inclusion:

  1. Men and women with interstitial cystitis/painful bladder syndrome greater than 18 years old
  2. Male and female controls without a history of IC/PBS diagnosis

Exclusion:

1. Unable to complete questionnaires and/or give informed consent

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00817388

Locations
United States, Michigan
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073
Sponsors and Collaborators
William Beaumont Hospitals
Investigators
Principal Investigator: Michael Chancellor, MD William Beaumont Hospitals
  More Information

No publications provided

Responsible Party: Michael Chancellor, MD, Beaumont Hospitals
ClinicalTrials.gov Identifier: NCT00817388     History of Changes
Other Study ID Numbers: 2008-294
Study First Received: January 5, 2009
Last Updated: June 4, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by William Beaumont Hospitals:
Interstitial cystitis
pelvic pain

Additional relevant MeSH terms:
Cystitis
Cystitis, Interstitial
Pelvic Pain
Pain
Signs and Symptoms
Urinary Bladder Diseases
Urologic Diseases

ClinicalTrials.gov processed this record on October 21, 2014